Incentives for market penetration of biosimilars in Belgium and in five European countries.
about
Key drivers for market penetration of biosimilars in Europe.Supply-side and demand-side policies for biosimilars: an overview in 10 European member states.Patient Access, Unmet Medical Need, Expected Benefits, and Concerns Related to the Utilisation of Biosimilars in Eastern European Countries: A Survey of Experts.
P2860
Incentives for market penetration of biosimilars in Belgium and in five European countries.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Incentives for market penetrat ...... nd in five European countries.
@en
type
label
Incentives for market penetrat ...... nd in five European countries.
@en
prefLabel
Incentives for market penetrat ...... nd in five European countries.
@en
P2093
P1476
Incentives for market penetrat ...... nd in five European countries.
@en
P2093
Farfan-Portet
N Swartenbroekx
P577
2014-12-01T00:00:00Z